Interviews

Julie Dopheide, PharmD, BCPP, FASHP, outlines several counseling points for treating patients with depression, anxiety and insomnia.

Julie Dopheide, PharmD, BCPP, FASHP, describes sleep hygiene recommendations pharmacists can give to patients experiencing insomnia.

Jon Roth, CEO of the California Pharmacists Association, offers guidance and advice for state pharmacy associations with respect to naloxone dispensing laws.

Neil Williams, PharmD, CPP, Clinical Pharmacist Coordinator for Community Care of North Carolina, discusses the key components of an effective pharmacy team.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the competitive advantages that independent pharmacies have over their retail pharmacy counterparts.

Neil Williams, PharmD, CPP, Clinical Pharmacist Coordinator for Community Care of North Carolina, discusses how pharmacists can better utilize their pharmacy technicians.

Neil Williams, PharmD, CPP, Clinical Pharmacist Coordinator for Community Care of North Carolina, discusses how the responsibilities assumed by pharmacy technicians during care transitions will continue to evolve.

Neil Williams, PharmD, CPP, Clinical Pharmacist Coordinator for Community Care of North Carolina, discusses the roles that pharmacy technicians play during care transitions.

Joe Moose, owner of Moose Professional Pharmacy, discusses how pharmacy technicians can better prepare themselves for the shifting pharmacy landscape.

Joe Moose, owner of Moose Professional Pharmacy, discusses the new responsibilities that pharmacy technicians are assuming.

Joe Moose, owner of Moose Professional Pharmacy, discusses how the roles of pharmacy technicians have changed.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses methods specialty pharmacies can use to help patients access high cost medications.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses how the movement toward value-based care has changed independent pharmacists' business goals.

Jerry McKee, PharmD, assistant director of Community Care of North Carolina, discusses the goals of the Pharmacy Home Project.

Jerry McKee, PharmD, assistant director of Community Care of North Carolina, discusses his organization's mission.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the technology trends that independent pharmacists should endeavor to familiarize themselves with.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the challenges independent pharmacists face with respect to customer retention efforts.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can leverage technology to improve the consumer experience.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses the benefits of MedImpact's iRx program.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the relationship between specialty pharmacies and accountable care organizations.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the potential of biosimilars to reduce the cost burden of specialty pharmaceuticals.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses how specialty pharmacies can enhance their operations with data analytics.

David Lassen, chief clinical officer at Prime Therapeutics, discusses important developments in specialty pharmacy.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses what comprises an effective pharmacy accreditation program.

Marc O'Connor, chief operating officer of Curant Health, discusses potential changes patients of specialty pharmacies may experience in the near future.

David Lassen, chief clinical officer at Prime Therapeutics, discusses how high cost hepatitis C drugs have impacted the entire specialty landscape.